Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Current Evidence on the Efficacy of Convalescent Plasma to Treat COVID-19

In this presentation, Professor Jens D. Lundgren discusses the theory behind using convalescent plasma to treat infectious disease and the current evidence and recommendations regarding its use to treat patients with COVID-19.
Jens D. Lundgren, MD, DMSc
Released: September 11, 2020

Information on this Educational Activity

Faculty

Jens D. Lundgren, MD, DMSc

Professor
Rigshospital, University of Copenhagen
Copenhagen, Denmark
Director
Centre of Excellence for Health, Immunity and Infection (CHIP)
Rigshospital, University of Copenhagen
Copenhagen, Denmark

Jens D. Lundgren, MD, DMSc, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

Dr. Jens Lundgren discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19 from CCO

Jens D. Lundgren, MD, DMSc Released: October 16, 2020

Barbara Rath, MD, PhD, HDR, discusses emerging COVID-19 data reported at the Virtual ECCVID 2020 Conference, in the CCO Infectious Disease podcast

Released: October 16, 2020

Downloadable slides from CCO expert, Dr. Barbara Rath, summarizing new ECCVID data on COVID-19 transmission, pathogenesis, treatment, and prevention

Barbara Rath, MD, PhD, HDR Released: October 9, 2020

Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Sharon R. Lewin, AO, FRACP, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: October 9, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue